Common GMP Supplier Audit Findings & How to Avoid Them

GMP Supplier Audit are a critical component of GMP compliance in the pharmaceutical industry. Regulatory authorities such as the MHRA, FDA, EMA, and Health Canada expect pharmaceutical companies to maintain effective oversight of their suppliers. Failing to comply can result in inspection findings, supply chain disruptions, and regulatory sanctions.

At PHARMALANE UK, our GMP supplier audit services are designed to identify risks, improve supplier compliance, and reduce regulatory exposure. Understanding the most common GMP supplier audit findings — and how to proactively address them — is essential for any pharmaceutical organization aiming to achieve audit readiness and regulatory compliance.

1. Inadequate Quality Management Systems (QMS)

A common finding in GMP supplier audits is a weak or poorly implemented Quality Management System (QMS). Inspectors often observe outdated procedures, lack of change control, or ineffective deviation management.

How to Avoid:

• Ensure suppliers maintain current SOPs aligned with GMP standards
• Verify that deviation and CAPA processes are documented and followed
• Assess management oversight and quality culture during audits

2. Poor Documentation Practices

Incomplete, inconsistent, or inaccurate documentation is another frequent GMP observation. Missing batch records or uncontrolled forms can result in regulatory non-compliance.

How to Avoid:

• Evaluate data integrity and documentation controls during audits
• Ensure adherence to ALCOA+ principles
• Confirm document control systems are regularly reviewed

3. Insufficient Supplier Qualification & Oversight

Many audit findings stem from insufficient supplier qualification or lack of ongoing monitoring. Regulatory authorities expect a risk-based approach to supplier management.

How to Avoid:

• Implement a documented supplier qualification program
• Conduct initial and periodic re-audits based on risk level
• Maintain clear quality agreements with suppliers

4. Training & Competency Gaps

Inspectors often flag suppliers with inadequate training records for personnel performing critical tasks.

How to Avoid:

• Review training matrices and verify role-specific GMP training
• Assess the effectiveness of ongoing training programs

5. CAPA Management Deficiencies

Unclosed or ineffective CAPAs after prior audits remain a frequent observation.

How to Avoid:

• Evaluate CAPA root cause analysis quality
• Ensure CAPAs are tracked and completed on time
• Perform follow-up audits when necessary

Conclusion

Identifying and addressing common GMP supplier audit findings is critical for regulatory compliance and maintaining high-quality standards. A strong supplier audit program, risk-based oversight, and effective CAPA management ensure inspection readiness and operational excellence. Staying aligned with GMP regulatory guidelines further supports organizations in maintaining compliance across global regulatory expectations.